Risk factors for an adverse outcome of HIV infection associated with cytopenia
https://doi.org/10.31549/2542-1174-2023-7-2-7-16
Abstract
I n t r o d u c t i o n . The appearance of hematological abnormalities since the beginning of the HIV-infection epidemic has been associated with an increased risk of disease progression and death in these patients.
A i m . Determination of risk factors for an adverse outcome in patients with HIV infection and cytopenia.
M a t e r i a l s a n d m e t h o d s . Hemograms and myelograms were analyzed in 30 hospitalized patients with HIV infection and cytopenia. All patients had two- or three-lineage cytopenia according to hemogram (anemia and thrombocytopenia, anemia and leukopenia, pancytopenia). Two groups of patients were assigned: in 18 (60%) patients the hospitalization had fatal outcome – group 1 (adverse outcome of the disease); and 12 (40%) patients were discharged from the hospital – group 2 (favorable outcome of the disease).
R e s u l t s . While evaluating the hemograms in patients with HIV infection and cytopenia with diff erent outcomes of the disease, no statistically signifi cant diff erences were found. Analysis of the bone marrow cellularity showed that the hypocellular and normocellular bone marrow were more often recorded in myelograms of group 1 patients; hypercellular bone marrow was not detected in group 1 patients, in group 2 patients it was determined in 4 cases (33.3%). The cellularity of the erythroid lineage was more often decreased in patients of group 2, normal and increased – in patients of group 1. The granulocyte lineage was more often suppressed in patients of group 1, was normal in patients of group 2, stimulated more often in patients of group 1. The megakaryocyte lineage more often had a decreased cellularity in group 1 patients; normocellularity of the megakaryocyte lineage was in group 2 patients; hypercellularity of the megakaryocyte lineage was not registered in the study groups. When comparing the signs of myelodysplasia in 13 patients of group 1, signs of dyspoiesis were revealed.
C o n c l u s i o n . In patients with HIV infection and cytopenia, as the underlying disease progresses, severe hematological disorders develop, which, in turn, may be risk factors for an adverse outcome of HIV infection.
About the Authors
D. V. Kalashnikova
Omsk State Medical University; Clinical Tuberculosis Dispensary No. 4
Russian Federation
Russian Federation
Daria V. Kalashnikova – Assistant, Department of Hospital Therapy, Endocrinology; Hematologist, Department of Hematology and Chemotherapy
12, Lenina str., Omsk, 644099
A. V. Mordyk
Omsk State Medical University
Russian Federation
Russian Federation
Anna V. Mordyk – Dr. Sci. (Med.), Professor, Head, Department of Phthisiology, Phthisiosurgery and Infectious Diseases
Omsk
L. V. Puzyreva
Omsk State Medical University; Regional Clinical Hospital
Russian Federation
Russian Federation
Larisa V. Puzyreva – Dr. Sci. (Med.), Associate Professor, Department of Phthisiology, Phthisiosurgery and Infectious Diseases; Infectious Disease Physician
Omsk
References
1. Durandt C., Potgieter J.C., Mellet J. et al. HIV and haematopoiesis. S. Afr. Med. J. 2019;109(8b):40-45. DOI: 10.7196/SAMJ.2019.v109i8b.13829.
2. Cao G., Wang Y., Wu Y. et al. Prevalence of anemia among people living with HIV: A systematic review and meta-analysis. EClinicalMedicine. 2022;44:101283. DOI: 10.1016/j.eclinm.2022.101283.
3. Bhatta L., Klouman E., Deuba K. et al. Survival on antiretroviral treatment among adult HIV-infected patients in Nepal: a retrospective cohort study in Far-western region, 2006–2011. BMC Infect. Dis. 2013;13:604. DOI: 10.1186/1471-2334-13-604.
4. Damtie S., Workineh L., Kiros T. et al. Hematological abnormalities of adult HIV-infected patients before and after initiation of highly active antiretroviral treatment at Debre Tabor Comprehensive Specialized Hospital, Northcentral Ethiopia: a cross-sectional study. HIV AIDS (Auckl). 2021;13:477-484. DOI: 10.2147/HIV.S308422.
5. Yu.N. Andreev, Z.S. Barkagan, A.Y. Bulanov et al. (2005). Guide to Hematology: in 3 vol., 3rd ed., revised. Moscow: Newdiamed. Vol. 3. 416 p. (In Russ.)
6. Akinbami A., Oshinaike O., Adeyemo T. et al. Hematologic abnormalities in treatment-naïve HIV patients. Infect. Dis. Res. Treat. 2010. Vol. 3. DOI: 10.4137/IDRT.S6033.
7. Enawgaw B., Alem M., Addis Z., Melku M. Determination of hematological and immunological parameters among HIV positive patients taking highly active antiretroviral treatment and treatment naïve in the antiretroviral therapy clinic of Gondar University Hospital, Gondar, Northwest Ethiopia: a comparative crosssectional study. BMC Hematol. 2014;14(1):8. DOI: 10.1186/2052-1839-14-8.
8. Shen Y., Wang J., Wang Z. et al. A cross-sectional study of leukopenia and thrombocytopenia among Chinese adults with newly diagnosed HIV/AIDS. Biosci. Trends. 2015;9(2):91-96. DOI: 10.5582/bst.2015.01024.
9. Kanestri V.G. Disorders of hemopoiesis in HIV patients. HIV infection and Immunosuppressive Disorders. 2017;9(2):7-15. DOI: 10.22328/2077-9828-2017-9-2-7-15. (In Russ.)
10. Ciccacci F., Lucaroni F., Latagliata R. et al. Hematologic alterations and early mortality in a cohort of HIV positive African patients. PLoS One. 2020;15(11):e0242068. DOI: 10.1371/journal.pone.0242068.
11. Johannessen A., Naman E., Ngowi B.J. et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect. Dis. 2008;8:52. DOI: 10.1186/1471-2334-8-52.
Review
For citations:
Kalashnikova D.V., Mordyk A.V., Puzyreva L.V. Risk factors for an adverse outcome of HIV infection associated with cytopenia. Journal of Siberian Medical Sciences. 2023;(2):7-16. (In Russ.) https://doi.org/10.31549/2542-1174-2023-7-2-7-16
Views:
255
Email this article 